Back to Search Start Over

Pulmonary-to-Systemic Arterial Shunt to Treat Children With Severe Pulmonary Hypertension.

Authors :
Grady, R. Mark
Canter, Matthew W.
Wan, Fei
Shmalts, Anton A.
Coleman, Ryan D.
Beghetti, Maurice
Berger, Rolf M.F.
del Cerro Marin, Maria J.
Fletcher, Scott E.
Hirsch, Russel
Humpl, Tilman
Ivy, D. Dunbar
Kirkpatrick, Edward C.
Kulik, Thomas J.
Levy, Marilyne
Moledina, Shahin
Yung, Delphine
Eghtesady, Pirooz
Bonnet, Damien
International Registry Potts Shunt
Source :
Journal of the American College of Cardiology (JACC). Aug2021, Vol. 78 Issue 5, p468-477. 10p.
Publication Year :
2021

Abstract

<bold>Background: </bold>The placement of a pulmonary-to-systemic arterial shunt in children with severe pulmonary hypertension (PH) has been demonstrated, in relatively small studies, to be an effective palliation for their disease.<bold>Objectives: </bold>The aim of this study was to expand upon these earlier findings using an international registry for children with PH who have undergone a shunt procedure.<bold>Methods: </bold>Retrospective data were obtained from 110 children with PH who underwent a shunt procedure collected from 13 institutions in Europe and the United States.<bold>Results: </bold>Seventeen children died in-hospital postprocedure (15%). Of the 93 children successfully discharged home, 18 subsequently died or underwent lung transplantation (20%); the mean follow-up was 3.1 years (range: 25 days to 17 years). The overall 1- and 5-year freedom from death or transplant rates were 77% and 58%, respectively, and 92% and 68% for those discharged home, respectively. Children discharged home had significantly improved World Health Organization functional class (P < 0.001), 6-minute walk distances (P = 0.047) and lower brain natriuretic peptide levels (P < 0.001). Postprocedure, 59% of children were weaned completely from their prostacyclin infusion (P < 0.001). Preprocedural risk factors for dying in-hospital postprocedure included intensive care unit admission (hazard ratio [HR]: 3.2; P = 0.02), mechanical ventilation (HR: 8.3; P < 0.001) and extracorporeal membrane oxygenation (HR: 10.7; P < 0.001).<bold>Conclusions: </bold>A pulmonary-to-systemic arterial shunt can provide a child with severe PH significant clinical improvement that is both durable and potentially free from continuous prostacyclin infusion. Five-year survival is comparable to children undergoing lung transplantation for PH. Children with severely decompensated disease requiring aggressive intensive care are not good candidates for the shunt procedure. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
07351097
Volume :
78
Issue :
5
Database :
Academic Search Index
Journal :
Journal of the American College of Cardiology (JACC)
Publication Type :
Academic Journal
Accession number :
151467007
Full Text :
https://doi.org/10.1016/j.jacc.2021.05.039